Skip to main content

Table 1 Patient characteristics

From: Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer at a single institute in Japan

Age (y)

  

Median (range)

71 (50–83)

N

%

T stage

T1

 

34

24

 

T2

 

40

28

 

T3

 

67

48

Gleason score

<8

 

73

52

 

8 − 10

 

68

48

Initial PSA

≤20

 

93

66

 

>20

 

48

34

NCCN riskGroup

IR

 

36

26

 

HR

 

105

74

ADT

 

Yes

124

88

  

IR

24

17

  

HR

100

71

  

STADT

27

22

  

LTADT

97

78

  

No

17

12

Diabetes

  

23

16

Hypertension

  

50

35

Hemorrhoid

  

37

26

  1. Abbreviations: PSA, prostate-specific antigen; NCCN, national comprehensive cancer network; IR, intermediate risk; HR, high risk; ADT, androgen-deprivation therapy; STADT, short-term ADT; LTADT, long-term ADT.
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us